90 results
The mediating role of health behaviors in the association between depression, anxiety and cancer incidence: an individual participant data meta-analysis
- Kuan-Yu Pan, Lonneke van Tuijl, Maartje Basten, Judith J. M. Rijnhart, Alexander de Graeff, Joost Dekker, Mirjam I. Geerlings, Adriaan Hoogendoorn, Adelita V. Ranchor, Roel Vermeulen, Lützen Portengen, Adri C. Voogd, Jessica Abell, Philip Awadalla, Aartjan T. F. Beekman, Ottar Bjerkeset, Andy Boyd, Yunsong Cui, Philipp Frank, Henrike Galenkamp, Bert Garssen, Sean Hellingman, Monika Hollander, Martijn Huisman, Anke Huss, Melanie R. Keats, Almar A. L. Kok, Steinar Krokstad, Flora E. van Leeuwen, Annemarie I. Luik, Nolwenn Noisel, Yves Payette, Brenda W. J. H. Penninx, Susan Picavet, Ina Rissanen, Annelieke M. Roest, Judith G. M. Rosmalen, Rikje Ruiter, Robert A. Schoevers, David Soave, Mandy Spaan, Andrew Steptoe, Karien Stronks, Erik R. Sund, Ellen Sweeney, Alison Teyhan, Emma L. Twait, Kimberly D. van der Willik, Femke Lamers
-
- Journal:
- Psychological Medicine , First View
- Published online by Cambridge University Press:
- 29 April 2024, pp. 1-14
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Background
Although behavioral mechanisms in the association among depression, anxiety, and cancer are plausible, few studies have empirically studied mediation by health behaviors. We aimed to examine the mediating role of several health behaviors in the associations among depression, anxiety, and the incidence of various cancer types (overall, breast, prostate, lung, colorectal, smoking-related, and alcohol-related cancers).
MethodsTwo-stage individual participant data meta-analyses were performed based on 18 cohorts within the Psychosocial Factors and Cancer Incidence consortium that had a measure of depression or anxiety (N = 319 613, cancer incidence = 25 803). Health behaviors included smoking, physical inactivity, alcohol use, body mass index (BMI), sedentary behavior, and sleep duration and quality. In stage one, path-specific regression estimates were obtained in each cohort. In stage two, cohort-specific estimates were pooled using random-effects multivariate meta-analysis, and natural indirect effects (i.e. mediating effects) were calculated as hazard ratios (HRs).
ResultsSmoking (HRs range 1.04–1.10) and physical inactivity (HRs range 1.01–1.02) significantly mediated the associations among depression, anxiety, and lung cancer. Smoking was also a mediator for smoking-related cancers (HRs range 1.03–1.06). There was mediation by health behaviors, especially smoking, physical inactivity, alcohol use, and a higher BMI, in the associations among depression, anxiety, and overall cancer or other types of cancer, but effects were small (HRs generally below 1.01).
ConclusionsSmoking constitutes a mediating pathway linking depression and anxiety to lung cancer and smoking-related cancers. Our findings underline the importance of smoking cessation interventions for persons with depression or anxiety.
4 Evaluating Plasma GFAP for the Detection of Alzheimer’s Disease Dementia
- Madeline Ally, Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton, Thomas K. Karikari, Hugo Aparicio, Michael A. Sugarman, Brandon Frank, Yorghos Tripodis, Ann C. McKee, Thor D. Stein, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Irene Simkina, Lindsay Farrer, Gyungah Jun, Katherine W. Turk, Andrew E. Budson, Maureen K. O’Connor, Rhoda Au, Wei Qiao Qiu, Lee E. Goldstein, Ronald Killiany, Neil W. Kowall, Robert A. Stern, Jesse Mez, Michael L. Alosco
-
- Journal:
- Journal of the International Neuropsychological Society / Volume 29 / Issue s1 / November 2023
- Published online by Cambridge University Press:
- 21 December 2023, pp. 408-409
-
- Article
-
- You have access Access
- Export citation
-
Objective:
Blood-based biomarkers represent a scalable and accessible approach for the detection and monitoring of Alzheimer’s disease (AD). Plasma phosphorylated tau (p-tau) and neurofilament light (NfL) are validated biomarkers for the detection of tau and neurodegenerative brain changes in AD, respectively. There is now emphasis to expand beyond these markers to detect and provide insight into the pathophysiological processes of AD. To this end, a reactive astrocytic marker, namely plasma glial fibrillary acidic protein (GFAP), has been of interest. Yet, little is known about the relationship between plasma GFAP and AD. Here, we examined the association between plasma GFAP, diagnostic status, and neuropsychological test performance. Diagnostic accuracy of plasma GFAP was compared with plasma measures of p-tau181 and NfL.
Participants and Methods:This sample included 567 participants from the Boston University (BU) Alzheimer’s Disease Research Center (ADRC) Longitudinal Clinical Core Registry, including individuals with normal cognition (n=234), mild cognitive impairment (MCI) (n=180), and AD dementia (n=153). The sample included all participants who had a blood draw. Participants completed a comprehensive neuropsychological battery (sample sizes across tests varied due to missingness). Diagnoses were adjudicated during multidisciplinary diagnostic consensus conferences. Plasma samples were analyzed using the Simoa platform. Binary logistic regression analyses tested the association between GFAP levels and diagnostic status (i.e., cognitively impaired due to AD versus unimpaired), controlling for age, sex, race, education, and APOE e4 status. Area under the curve (AUC) statistics from receiver operating characteristics (ROC) using predicted probabilities from binary logistic regression examined the ability of plasma GFAP to discriminate diagnostic groups compared with plasma p-tau181 and NfL. Linear regression models tested the association between plasma GFAP and neuropsychological test performance, accounting for the above covariates.
Results:The mean (SD) age of the sample was 74.34 (7.54), 319 (56.3%) were female, 75 (13.2%) were Black, and 223 (39.3%) were APOE e4 carriers. Higher GFAP concentrations were associated with increased odds for having cognitive impairment (GFAP z-score transformed: OR=2.233, 95% CI [1.609, 3.099], p<0.001; non-z-transformed: OR=1.004, 95% CI [1.002, 1.006], p<0.001). ROC analyses, comprising of GFAP and the above covariates, showed plasma GFAP discriminated the cognitively impaired from unimpaired (AUC=0.75) and was similar, but slightly superior, to plasma p-tau181 (AUC=0.74) and plasma NfL (AUC=0.74). A joint panel of the plasma markers had greatest discrimination accuracy (AUC=0.76). Linear regression analyses showed that higher GFAP levels were associated with worse performance on neuropsychological tests assessing global cognition, attention, executive functioning, episodic memory, and language abilities (ps<0.001) as well as higher CDR Sum of Boxes (p<0.001).
Conclusions:Higher plasma GFAP levels differentiated participants with cognitive impairment from those with normal cognition and were associated with worse performance on all neuropsychological tests assessed. GFAP had similar accuracy in detecting those with cognitive impairment compared with p-tau181 and NfL, however, a panel of all three biomarkers was optimal. These results support the utility of plasma GFAP in AD detection and suggest the pathological processes it represents might play an integral role in the pathogenesis of AD.
5 Antemortem Plasma GFAP Predicts Alzheimer’s Disease Neuropathological Changes
- Madeline Ally, Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton, Thomas K. Karikari, Hugo Aparicio, Michael A. Sugarman, Brandon Frank, Yorghos Tripodis, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Irene Simkina, Lindsay Farrer, Gyungah Jun, Katherine W. Turk, Andrew E. Budson, Maureen K. O’Connor, Rhoda Au, Wei Qiao Qiu, Lee E. Goldstein, Ronald Killiany, Neil W. Kowall, Robert A. Stern, Jesse Mez, Bertran R. Huber, Ann C. McKee, Thor D. Stein, Michael L. Alosco
-
- Journal:
- Journal of the International Neuropsychological Society / Volume 29 / Issue s1 / November 2023
- Published online by Cambridge University Press:
- 21 December 2023, pp. 409-410
-
- Article
-
- You have access Access
- Export citation
-
Objective:
Blood-based biomarkers offer a more feasible alternative to Alzheimer’s disease (AD) detection, management, and study of disease mechanisms than current in vivo measures. Given their novelty, these plasma biomarkers must be assessed against postmortem neuropathological outcomes for validation. Research has shown utility in plasma markers of the proposed AT(N) framework, however recent studies have stressed the importance of expanding this framework to include other pathways. There is promising data supporting the usefulness of plasma glial fibrillary acidic protein (GFAP) in AD, but GFAP-to-autopsy studies are limited. Here, we tested the association between plasma GFAP and AD-related neuropathological outcomes in participants from the Boston University (BU) Alzheimer’s Disease Research Center (ADRC).
Participants and Methods:This sample included 45 participants from the BU ADRC who had a plasma sample within 5 years of death and donated their brain for neuropathological examination. Most recent plasma samples were analyzed using the Simoa platform. Neuropathological examinations followed the National Alzheimer’s Coordinating Center procedures and diagnostic criteria. The NIA-Reagan Institute criteria were used for the neuropathological diagnosis of AD. Measures of GFAP were log-transformed. Binary logistic regression analyses tested the association between GFAP and autopsy-confirmed AD status, as well as with semi-quantitative ratings of regional atrophy (none/mild versus moderate/severe) using binary logistic regression. Ordinal logistic regression analyses tested the association between plasma GFAP and Braak stage and CERAD neuritic plaque score. Area under the curve (AUC) statistics from receiver operating characteristics (ROC) using predicted probabilities from binary logistic regression examined the ability of plasma GFAP to discriminate autopsy-confirmed AD status. All analyses controlled for sex, age at death, years between last blood draw and death, and APOE e4 status.
Results:Of the 45 brain donors, 29 (64.4%) had autopsy-confirmed AD. The mean (SD) age of the sample at the time of blood draw was 80.76 (8.58) and there were 2.80 (1.16) years between the last blood draw and death. The sample included 20 (44.4%) females, 41 (91.1%) were White, and 20 (44.4%) were APOE e4 carriers. Higher GFAP concentrations were associated with increased odds for having autopsy-confirmed AD (OR=14.12, 95% CI [2.00, 99.88], p=0.008). ROC analysis showed plasma GFAP accurately discriminated those with and without autopsy-confirmed AD on its own (AUC=0.75) and strengthened as the above covariates were added to the model (AUC=0.81). Increases in GFAP levels corresponded to increases in Braak stage (OR=2.39, 95% CI [0.71-4.07], p=0.005), but not CERAD ratings (OR=1.24, 95% CI [0.004, 2.49], p=0.051). Higher GFAP levels were associated with greater temporal lobe atrophy (OR=10.27, 95% CI [1.53,69.15], p=0.017), but this was not observed with any other regions.
Conclusions:The current results show that antemortem plasma GFAP is associated with non-specific AD neuropathological changes at autopsy. Plasma GFAP could be a useful and practical biomarker for assisting in the detection of AD-related changes, as well as for study of disease mechanisms.
P.002 Saccade parameters reveal cognitive impairment and differentially associate with cognitive domains across neurodegenerative diseases
- HC Riek, BC Coe, DC Brien, J Huang, A Abrahao, S Arnott, D Beaton, M Binns, S Black, M Borrie, L Casaubon, D Dowlatshahi, E Finger, C Fischer, A Frank, M Freedman, D Grimes, A Hassan, M Jog, S Kumar, D Kwan, A Lang, J Lawrence Dewar, B Levine, W Lou, J Mandzia, C Marras, M Masellis, P McLaughlin, J Orange, S Pasternak, A Peltsch, B Pollock, T Rajji, A Roberts, D Sahlas, G Saposnik, D Seitz, C Shoesmith, T Steeves, S Strother, S Sujanthan, K Sunderland, R Swartz, B Tan, D Tang-Wai, C Tartaglia, A Troyer, J Turnbull, L Zinman, ONDRI Investigators (), DP Munoz
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, p. S8
-
- Article
-
- You have access Access
- Export citation
-
Background: Eye movements reveal neurodegenerative disease processes due to overlap between oculomotor circuitry and disease-affected areas. Characterizing oculomotor behaviour in context of cognitive function may enhance disease diagnosis and monitoring. We therefore aimed to quantify cognitive impairment in neurodegenerative disease using saccade behaviour and neuropsychology. Methods: The Ontario Neurodegenerative Disease Research Initiative recruited individuals with neurodegenerative disease: one of Alzheimer’s disease, mild cognitive impairment, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson’s disease, or cerebrovascular disease. Patients (n=450, age 40-87) and healthy controls (n=149, age 42-87) completed a randomly interleaved pro- and anti-saccade task (IPAST) while their eyes were tracked. We explored the relationships of saccade parameters (e.g. task errors, reaction times) to one another and to cognitive domain-specific neuropsychological test scores (e.g. executive function, memory). Results: Task performance worsened with cognitive impairment across multiple diseases. Subsets of saccade parameters were interrelated and also differentially related to neuropsychology-based cognitive domain scores (e.g. antisaccade errors and reaction time associated with executive function). Conclusions: IPAST detects global cognitive impairment across neurodegenerative diseases. Subsets of parameters associate with one another, suggesting disparate underlying circuitry, and with different cognitive domains. This may have implications for use of IPAST as a cognitive screening tool in neurodegenerative disease.
Comparing optimized exoskeleton assistance of the hip, knee, and ankle in single and multi-joint configurations
- Patrick W. Franks, Gwendolyn M. Bryan, Russell M. Martin, Ricardo Reyes, Ava C. Lakmazaheri, Steven H. Collins
-
- Journal:
- Wearable Technologies / Volume 2 / 2021
- Published online by Cambridge University Press:
- 24 November 2021, e16
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Exoskeletons that assist the hip, knee, and ankle joints have begun to improve human mobility, particularly by reducing the metabolic cost of walking. However, direct comparisons of optimal assistance of these joints, or their combinations, have not yet been possible. Assisting multiple joints may be more beneficial than the sum of individual effects, because muscles often span multiple joints, or less effective, because single-joint assistance can indirectly aid other joints. In this study, we used a hip–knee–ankle exoskeleton emulator paired with human-in-the-loop optimization to find single-joint, two-joint, and whole-leg assistance that maximally reduced the metabolic cost of walking. Hip-only and ankle-only assistance reduced the metabolic cost of walking by 26 and 30% relative to walking in the device unassisted, confirming that both joints are good targets for assistance (N = 3). Knee-only assistance reduced the metabolic cost of walking by 13%, demonstrating that effective knee assistance is possible (N = 3). Two-joint assistance reduced the metabolic cost of walking by between 33 and 42%, with the largest improvements coming from hip-ankle assistance (N = 3). Assisting all three joints reduced the metabolic cost of walking by 50%, showing that at least half of the metabolic energy expended during walking can be saved through exoskeleton assistance (N = 4). Changes in kinematics and muscle activity indicate that single-joint assistance indirectly assisted muscles at other joints, such that the improvement from whole-leg assistance was smaller than the sum of its single-joint parts. Exoskeletons can assist the entire limb for maximum effect, but a single well-chosen joint can be more efficient when considering additional factors such as weight and cost.
Characterisation of age and polarity at onset in bipolar disorder
- Janos L. Kalman, Loes M. Olde Loohuis, Annabel Vreeker, Andrew McQuillin, Eli A. Stahl, Douglas Ruderfer, Maria Grigoroiu-Serbanescu, Georgia Panagiotaropoulou, Stephan Ripke, Tim B. Bigdeli, Frederike Stein, Tina Meller, Susanne Meinert, Helena Pelin, Fabian Streit, Sergi Papiol, Mark J. Adams, Rolf Adolfsson, Kristina Adorjan, Ingrid Agartz, Sofie R. Aminoff, Heike Anderson-Schmidt, Ole A. Andreassen, Raffaella Ardau, Jean-Michel Aubry, Ceylan Balaban, Nicholas Bass, Bernhard T. Baune, Frank Bellivier, Antoni Benabarre, Susanne Bengesser, Wade H Berrettini, Marco P. Boks, Evelyn J. Bromet, Katharina Brosch, Monika Budde, William Byerley, Pablo Cervantes, Catina Chillotti, Sven Cichon, Scott R. Clark, Ashley L. Comes, Aiden Corvin, William Coryell, Nick Craddock, David W. Craig, Paul E. Croarkin, Cristiana Cruceanu, Piotr M. Czerski, Nina Dalkner, Udo Dannlowski, Franziska Degenhardt, Maria Del Zompo, J. Raymond DePaulo, Srdjan Djurovic, Howard J. Edenberg, Mariam Al Eissa, Torbjørn Elvsåshagen, Bruno Etain, Ayman H. Fanous, Frederike Fellendorf, Alessia Fiorentino, Andreas J. Forstner, Mark A. Frye, Janice M. Fullerton, Katrin Gade, Julie Garnham, Elliot Gershon, Michael Gill, Fernando S. Goes, Katherine Gordon-Smith, Paul Grof, Jose Guzman-Parra, Tim Hahn, Roland Hasler, Maria Heilbronner, Urs Heilbronner, Stephane Jamain, Esther Jimenez, Ian Jones, Lisa Jones, Lina Jonsson, Rene S. Kahn, John R. Kelsoe, James L. Kennedy, Tilo Kircher, George Kirov, Sarah Kittel-Schneider, Farah Klöhn-Saghatolislam, James A. Knowles, Thorsten M. Kranz, Trine Vik Lagerberg, Mikael Landen, William B. Lawson, Marion Leboyer, Qingqin S. Li, Mario Maj, Dolores Malaspina, Mirko Manchia, Fermin Mayoral, Susan L. McElroy, Melvin G. McInnis, Andrew M. McIntosh, Helena Medeiros, Ingrid Melle, Vihra Milanova, Philip B. Mitchell, Palmiero Monteleone, Alessio Maria Monteleone, Markus M. Nöthen, Tomas Novak, John I. Nurnberger, Niamh O'Brien, Kevin S. O'Connell, Claire O'Donovan, Michael C. O'Donovan, Nils Opel, Abigail Ortiz, Michael J. Owen, Erik Pålsson, Carlos Pato, Michele T. Pato, Joanna Pawlak, Julia-Katharina Pfarr, Claudia Pisanu, James B. Potash, Mark H Rapaport, Daniela Reich-Erkelenz, Andreas Reif, Eva Reininghaus, Jonathan Repple, Hélène Richard-Lepouriel, Marcella Rietschel, Kai Ringwald, Gloria Roberts, Guy Rouleau, Sabrina Schaupp, William A Scheftner, Simon Schmitt, Peter R. Schofield, K. Oliver Schubert, Eva C. Schulte, Barbara Schweizer, Fanny Senner, Giovanni Severino, Sally Sharp, Claire Slaney, Olav B. Smeland, Janet L. Sobell, Alessio Squassina, Pavla Stopkova, John Strauss, Alfonso Tortorella, Gustavo Turecki, Joanna Twarowska-Hauser, Marin Veldic, Eduard Vieta, John B. Vincent, Wei Xu, Clement C. Zai, Peter P. Zandi, Psychiatric Genomics Consortium (PGC) Bipolar Disorder Working Group, International Consortium on Lithium Genetics (ConLiGen), Colombia-US Cross Disorder Collaboration in Psychiatric Genetics, Arianna Di Florio, Jordan W. Smoller, Joanna M. Biernacka, Francis J. McMahon, Martin Alda, Bertram Müller-Myhsok, Nikolaos Koutsouleris, Peter Falkai, Nelson B. Freimer, Till F.M. Andlauer, Thomas G. Schulze, Roel A. Ophoff
-
- Journal:
- The British Journal of Psychiatry / Volume 219 / Issue 6 / December 2021
- Published online by Cambridge University Press:
- 25 August 2021, pp. 659-669
- Print publication:
- December 2021
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Background
Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools.
AimsTo examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics.
MethodGenome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts.
ResultsEarlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = −0.34 years, s.e. = 0.08), major depression (β = −0.34 years, s.e. = 0.08), schizophrenia (β = −0.39 years, s.e. = 0.08), and educational attainment (β = −0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO.
ConclusionsAAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.
The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces – ERRATUM
- Pascal-M Aggensteiner, Nathalie E. Holz, Boris W. Böttinger, Sarah Baumeister, Sarah Hohmann, Julia E. Werhahn, Jilly Naaijen, Shahrzad Ilbegi, Jeffrey C. Glennon, Pieter J. Hoekstra, Andrea Dietrich, Renee Kleine Deters, Melanie C. Saam, Ulrike M. E. Schulze, David J. Lythgoe, Arjun Sethi, Michael C. Craig, Mathilde Mastroianni, Ilyas Sagar-Ouriaghli, Paramala J. Santosh, Mireia Rosa, Nuria Bargallo, Josefina Castro-Fornieles, Celso Arango, Maria J. Penzol, Jorge Vidal, Barbara Franke, Marcel P. Zwiers, Jan K. Buitelaar, Susanne Walitza, Tobias Banaschewski, Daniel Brandeis
-
- Journal:
- Psychological Medicine / Volume 53 / Issue 1 / January 2023
- Published online by Cambridge University Press:
- 28 August 2020, p. 304
-
- Article
-
- You have access Access
- HTML
- Export citation
The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces
- Pascal-M Aggensteiner, Nathalie E. Holz, Boris W. Böttinger, Sarah Baumeister, Sarah Hohmann, Julia E. Werhahn, Jilly Naaijen, Shahrzad Ilbegi, Jeffrey C. Glennon, Pieter J. Hoekstra, Andrea Dietrich, Renee Kleine Deters, Melanie C. Saam, Ulrike M. E. Schulze, David J. Lythgoe, Arjun Sethi, Michael C. Craig, Mathilde Mastroianni, Ilyas Sagar-Ouriaghli, Paramala J. Santosh, Mireia Rosa, Nuria Bargallo, Josefina Castro-Fornieles, Celso Arango, Maria J. Penzol, Jorge Vidal, Barbara Franke, Marcel P. Zwiers, Jan K. Buitelaar, Susanne Walitza, Tobias Banaschewski, Daniel Brandeis
-
- Journal:
- Psychological Medicine / Volume 52 / Issue 3 / February 2022
- Published online by Cambridge University Press:
- 06 July 2020, pp. 476-484
-
- Article
- Export citation
-
Background
Brain imaging studies have shown altered amygdala activity during emotion processing in children and adolescents with oppositional defiant disorder (ODD) and conduct disorder (CD) compared to typically developing children and adolescents (TD). Here we aimed to assess whether aggression-related subtypes (reactive and proactive aggression) and callous-unemotional (CU) traits predicted variation in amygdala activity and skin conductance (SC) response during emotion processing.
MethodsWe included 177 participants (n = 108 cases with disruptive behaviour and/or ODD/CD and n = 69 TD), aged 8–18 years, across nine sites in Europe, as part of the EU Aggressotype and MATRICS projects. All participants performed an emotional face-matching functional magnetic resonance imaging task.
ResultsDifferences between cases and TD in affective processing, as well as specificity of activation patterns for aggression subtypes and CU traits, were assessed. Simultaneous SC recordings were acquired in a subsample (n = 63). Cases compared to TDs showed higher amygdala activity in response to negative faces (fearful and angry) v. shapes. Subtyping cases according to aggression-related subtypes did not significantly influence on amygdala activity; while stratification based on CU traits was more sensitive and revealed decreased amygdala activity in the high CU group. SC responses were significantly lower in cases and negatively correlated with CU traits, reactive and proactive aggression.
ConclusionsOur results showed differences in amygdala activity and SC responses to emotional faces between cases with ODD/CD and TD, while CU traits moderate both central (amygdala) and peripheral (SC) responses. Our insights regarding subtypes and trait-specific aggression could be used for improved diagnostics and personalized treatment.
5 - Diamonds and the Mantle Geodynamics of Carbon
-
- By Steven B. Shirey, Karen V. Smit, D. Graham Pearson, Michael J. Walter, Sonja Aulbach, Frank E. Brenker, Hélène Bureau, Antony D. Burnham, Pierre Cartigny, Thomas Chacko, Daniel J. Frost, Erik H. Hauri, Dorrit E. Jacob, Steven D. Jacobsen, Simon C. Kohn, Robert W. Luth, Sami Mikhail, Oded Navon, Fabrizio Nestola, Paolo Nimis, Mederic Palot, Evan M. Smith, Thomas Stachel, Vincenzo Stagno, Andrew Steele, Richard A. Stern, Emilie Thomassot, Andrew R. Thomson, Yaakov Weiss
- Edited by Beth N. Orcutt, Isabelle Daniel, Université Claude-Bernard Lyon I, Rajdeep Dasgupta, Rice University, Houston
-
- Book:
- Deep Carbon
- Published online:
- 03 October 2019
- Print publication:
- 17 October 2019, pp 89-128
-
- Chapter
-
- You have access Access
- Open access
- HTML
- Export citation
-
Summary
The science of studying diamond inclusions for understanding Earth history has developed significantly over the past decades, with new instrumentation and techniques applied to diamond sample archives revealing the stories contained within diamond inclusions. This chapter reviews what diamonds can tell us about the deep carbon cycle over the course of Earth’s history. It reviews how the geochemistry of diamonds and their inclusions inform us about the deep carbon cycle, the origin of the diamonds in Earth’s mantle, and the evolution of diamonds through time.
Supplementation of a Lactobacillus acidophilus fermentation product can attenuate the acute phase response following a lipopolysaccharide challenge in weaned pigs
- N. C. Burdick Sanchez, J. A. Carroll, P. R. Broadway, B. E. Bass, J. W. Frank
-
- Article
- Export citation
-
Lactobacillus acidophilus fermentation products have been used to improve the performance of nursery pigs. However, research on the influence of this supplement on health is lacking. This study was designed to determine if feeding a Lactobacillus acidophilus fermentation product to weaned pigs would reduce stress and acute phase responses (APR) following a lipopolysaccharide (LPS) challenge. Pigs (n=30; 6.4±0.1 kg) were individually housed in stainless steel pens with ad libitum access to feed and water. Pigs were weighed upon arrival, assigned to one of three groups (n=10/treatment), and fed for 18 days: (1) Control, fed a non-medicated starter diet; (2) Control diet with the inclusion of a Lactobacillus acidophilus fermentation product at 1 kg/metric ton (SGX1) and (3) Control diet with the inclusion of a Lactobacillus acidophilus fermentation product at 2 kg/metric ton (SGX2). On day 7 pigs were anesthetized for insertion of an i.p. temperature device, and similarly on day 14 for insertion of a jugular catheter. Pigs were challenged i.v. with LPS (25 µg/kg BW) on day 15. Blood samples were collected at 0.5 h (serum) and 1 h (complete blood cell counts) intervals from −2 to 8 h and at 24 h relative to LPS administration at 0 h. Pigs and feeders were weighed on days 7, 14 and 18. The supplemented pigs had increased BW and average daily gain before the challenge. In response to LPS, there was a greater increase in i.p. temperature in Control pigs compared with supplemented pigs. In addition, cortisol was reduced in SGX2 pigs while cortisol was elevated in SGX1 pigs at several time points post-challenge. White blood cells, neutrophils and lymphocytes were decreased in SGX1 and SGX2 compared with Control pigs. Furthermore, the pro-inflammatory cytokine response varied by treatment and dose of treatment. Specifically, serum TNF-α was greatest in SGX2, intermediate in Control, and least in SGX1 pigs, while the magnitude and temporal pattern of IFN-γ in SGX2 pigs was delayed and reduced. In contrast, IL-6 concentrations were reduced in both SGX treatment groups compared with Control pigs. These data demonstrate that different supplementation feed inclusion rates produced differential responses, and that feeding SynGenX to weaned pigs attenuated the APR to an LPS challenge.
Absorption, Translocation, and Metabolism of 14C-Halosulfuron in Grafted Eggplant and Tomato
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 31 / Issue 6 / December 2017
- Published online by Cambridge University Press:
- 27 September 2017, pp. 908-914
-
- Article
- Export citation
-
Grafted plants are a combination of two different interspecific or intraspecific scion and rootstock. Determination of herbicidal selectivity of the grafted plant is critical given their increased use in vegetable production. Differential absorption, translocation, and metabolism play an important role in herbicide selectivity of plant species because these processes affect the herbicide amount delivered to the site of action. Therefore, experiments were conducted to determine absorption, translocation, and metabolism of halosulfuron in grafted and non-grafted tomato and eggplant. Transplant type included non-grafted tomato cultivar Amelia, non-grafted eggplant cultivar Santana, Amelia scion grafted onto Maxifort tomato rootstock (A-Maxifort) and Santana scion grafted onto Maxifort rootstock (S-Maxifort). Plants were treated POST with commercially formulated halosulfuron at 39 g ai ha-1 followed by 14C-halosulfuron under controlled laboratory conditions. Amount of 14C-halosufuron was quantified in leaf wash, treated leaf, scion shoot, rootstock shoot, and root at 6, 12, 24, 48, and 96 h after treatment (HAT) using liquid scintillation spectrometry. No differences were observed between transplant types with regard to absorption and translocation of 14C-halosulfuron. Absorption of 14C-halosulfuron increased with time, reaching 10 and 74% of applied at 6 and 96 HAT, respectively. Translocation of 14C-halosulfuron was limited to the treated leaf, which reached maximum (66% of applied) at 96 HAT, whereas minimal (<4% of applied) translocation occurred in scion shoot, rootstock shoot, and root. Tomato plants metabolized halosulfuron faster compared to eggplant regardless of grafting. Of the total amount of 14C-halosulfuron absorbed into the plant, 9 to 14% remained in the form of the parent compound in tomato compared with 25 to 26% in eggplant at 48 HAT. These results indicate that grafting did not affect absorption, translocation, and metabolism of POST halosulfuron in tomato and eggplant.
Soybean (Glycine max) Response to Postemergence Herbicide Mixtures Containing 2,4-DB
- Alan C. York, John W. Wilcut, Mark M. Keene, Frank R. Walls, Jr.
-
- Journal:
- Weed Technology / Volume 5 / Issue 1 / March 1991
- Published online by Cambridge University Press:
- 12 June 2017, pp. 43-47
-
- Article
- Export citation
-
Experiments were conducted at 12 locations in North Carolina and Virginia to determine soybean response to postemergence application of 2,4-DB in combination with 420 g ae ha-1 of sodium salt of acifluorfen, 13 g ae ha-1 of ethyl ester of chlorimuron, and 70 g ae ha-1 of ammonium salt of imazethapyr. Adding dimethylamine salt of 2,4-DB at 35 or 70 g ae ha-1 to acifluorfen, chlorimuron, or imazethapyr increased soybean injury 2 to 14% 7 d after application. Soybean quickly recovered and no injury was observed 21 d after application. Acifluorfen, chlorimuron, or imazethapyr alone or in combination with 2,4-DB at 35 g ha-1 did not reduce soybean yield. Adding 2,4-DB at 70 g ha-1 reduced yield at four of the 12 locations.
Stability of corn (Zea mays)-foxtail (Setaria spp.) interference relationships
- John L. Lindquist, David A. Mortensen, Philip Westra, W. J. Lambert, Thomas T. Bauman, Jason C. Fausey, James J. Kells, Steven J. Langton, R. Gordon Harvey, Brett H. Bussler, Kevin Banken, Sharon Clay, Frank Forcella
-
- Journal:
- Weed Science / Volume 47 / Issue 2 / April 1999
- Published online by Cambridge University Press:
- 12 June 2017, pp. 195-200
-
- Article
- Export citation
-
Variation in interference relationships have been shown for a number of crop-weed associations and may have an important effect on the implementation of decision support systems for weed management. Multiyear field experiments were conducted at eight locations to determine the stability of corn-foxtail interference relationships across years and locations. Two coefficients (I and A) of a rectangular hyperbola equation were estimated for each data set using nonlinear regression procedures. The I and A coefficients represent percent corn yield loss as foxtail density approaches zero and maximum percent corn yield loss, respectively. The coefficient I was stable across years at two locations and varied across years at four locations. Maximum yield loss (A) varied between years at one location. Both coefficients varied among locations. Although 3 to 4 foxtail plants m−-1 row was a conservative estimate of the single-year economic threshold (Tc) of foxtail density, variation in I and A resulted in a large variation in Tc. Therefore, the utility of using common coefficient estimates to predict future crop yield loss from foxtail interference between years or among locations within a region is limited.
Response of Drought-Stressed Grafted and Nongrafted Tomato to Postemergence Metribuzin
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 31 / Issue 3 / June 2017
- Published online by Cambridge University Press:
- 31 May 2017, pp. 447-454
-
- Article
- Export citation
-
Tomato grafting is practiced worldwide as an innovative approach to manage stress from drought, waterlogging, insects, and diseases. Metribuzin is a commonly used herbicide in tomato but has potential to cause injury after application if plants are under stress. The influence of metribuzin on grafted tomato under drought-stress has not been studied. Greenhouse experiments were conducted in Raleigh, NC to determine the tolerance of drought-stressed grafted and non-grafted tomato to metribuzin. The tomato cultivar ‘Amelia’ was used as the scion in grafted tomato, and for the non-grafted control. Two hybrid tomato ‘Beaufort’ and ‘Maxifort’ were used as rootstocks for grafted plants. Drought-stress treatments included: no drought-stress; 3 d of drought-stress before metribuzin application with no drought-stress after application (3 d DSB); and 3 d of drought-stress before metribuzin application with 3 d of drought-stress after application (3 d DSBA). Metribuzin was applied at 550 g ai ha−1. No difference in injury from metribuzin was observed in grafted and non-grafted plants. However, at 7 and 14 d after metribuzin treatment (DMT), less injury was observed on tomato in the 3 d DSBA treatment (5 and 2% injury, respectively) than on plants in the 3 d DSB treatment (15 and 8% injury, respectively) or those that were never drought-stressed (18 and 11% injury, respectively). Photosynthesis and stomatal conductance measured prior to metribuzin application were reduced similarly in grafted and non-grafted tomato subjected to drought-stress. Photosynthesis and stomatal conductance of grafted and non-grafted tomato at 7 DMT was not different among drought-stress treatments or metribuzin treatments. Grafted and non-grafted tomato plants under drought-stress exhibit similar tolerance to metribuzin. The risk of metribuzin injury to grafted tomato under drought-stress is similar to non-grafted tomato.
Insensitive parenting may accelerate the development of the amygdala–medial prefrontal cortex circuit
- Sandra Thijssen, Ryan L. Muetzel, Marian J. Bakermans-Kranenburg, Vincent W. V. Jaddoe, Henning Tiemeier, Frank C. Verhulst, Tonya White, Marinus H. Van Ijzendoorn
-
- Journal:
- Development and Psychopathology / Volume 29 / Issue 2 / May 2017
- Published online by Cambridge University Press:
- 12 April 2017, pp. 505-518
-
- Article
- Export citation
-
This study examined whether the association between age and amygdala–medial prefrontal cortex (mPFC) connectivity in typically developing 6- to 10-year-old children is correlated with parental care. Resting-state functional magnetic resonance imaging scans were acquired from 124 children of the Generation R Study who at 4 years old had been observed interacting with their parents to assess maternal and paternal sensitivity. Amygdala functional connectivity was assessed using a general linear model with the amygdalae time series as explanatory variables. Higher level analyses assessing Sensitivity × Age as well as exploratory Sensitivity × Age × Gender interaction effects were performed restricted to voxels in the mPFC. We found significant Sensitivity × Age interaction effects on amygdala–mPFC connectivity. Age was related to stronger amygdala–mPFC connectivity in children with a lower combined parental sensitivity score (b = 0.11, p = .004, b = 0.06, p = .06, right and left amygdala, respectively), but not in children with a higher parental sensitivity score, (b = –0.07, p = .12, b = –0.06, p = .12, right and left amygdala, respectively). A similar effect was found for maternal sensitivity, with stronger amygdala–mPFC connectivity in children with less sensitive mothers. Exploratory (parental, maternal, paternal) Sensitivity × Age × Gender interaction analyses suggested that this effect was especially pronounced in girls. Amygdala-mPFC resting-state functional connectivity has been shown to increase from age 10.5 years onward, implying that the positive association between age and amygdala–mPFC connectivity in 6- to 10-year-old children of less sensitive parents represents accelerated development of the amygdala–mPFC circuit.
Response of Eggplant (Solanum melongena) Grafted onto Tomato (Solanum lycopersicum) Rootstock to Herbicides
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Nicholas T. Basinger, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 30 / Issue 1 / March 2016
- Published online by Cambridge University Press:
- 20 January 2017, pp. 207-216
-
- Article
- Export citation
-
Tomato rootstocks have been successfully used for eggplant production. However, the safety of herbicides registered in tomato has not been tested on grafted eggplant, which is a combination of tomato rootstock and eggplant scion. Greenhouse and field experiments were conducted to determine response of grafted eggplant on tomato rootstock to napropamide, metribuzin, halosulfuron, trifluralin, S-metolachlor, and fomesafen herbicides. In greenhouse experiments, herbicide treatments included pretransplant S-metolachlor (400 and 800 g ai ha−1), pre- or posttransplant metribuzin (140 and 280 g ai ha−1), and posttransplant halosulfuron (18 and 36 g ai ha−1). In field experiments, herbicide treatments included pretransplant fomesafen (280 and 420 g ai ha−1), halosulfuron (39 and 52 g ha−1), metribuzin (280 and 550 g ha−1), napropamide (1,120 and 2,240 g ai ha−1), S-metolachlor (800 and 1,060 g ha−1), and trifluralin (560 and 840 g ai ha−1). The eggplant cultivar ‘Santana' was used as the scion and nongrafted control, and two hybrid tomatoes ‘RST-04−106-T' and ‘Maxifort' were used as rootstocks for grafted plants. In both greenhouse and field experiments, there was no difference between grafted and nongrafted eggplant in terms of injury caused by herbicides. Metribuzin posttransplant at 140 and 280 g ha−1 caused 94 and 100% injury to grafted and nongrafted eggplant 4 wk after treatment. In field experiments, pretransplant fomesafen, napropamide, S-metolachlor, and trifluralin caused less than 10% injury and no yield reduction in grafted and nongrafted eggplant. However, metribuzin caused injury and yield reduction in both grafted and nongrafted eggplant. Metribuzin at 550 g ha−1 caused 60 and 81% plant stand loss in 2013 and 2014, respectively. Halosulfuron reduced yield 24% in both grafted and nongrafted eggplant compared to nontreated control in 2013 but did not reduce yield in 2014. The pretransplant S-metolachlor, napropamide, fomesafen, and trifluralin are safe to use on eggplant grafted onto tomato rootstock, and will be a valuable addition to the toolkit of eggplant growers.
Response of Grafted Tomato (Solanum lycopersicum) to Herbicides
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 29 / Issue 4 / December 2015
- Published online by Cambridge University Press:
- 20 January 2017, pp. 800-809
-
- Article
- Export citation
-
Tomato grafting has gained increased attention in the United States as an alternative to methyl bromide to control soilborne pests and diseases. Although several herbicides are registered in tomato production, a lack of information exists on the effect of herbicides on grafted tomato. Greenhouse and field experiments were conducted to determine herbicide tolerance of grafted tomato. In greenhouse experiments, halosulfuron (27, 54, and 108 g ai ha−1), metribuzin (280, 560, and 1,120 g ai ha−1), and S-metolachlor (1,070, 2,140, and 3,200 g ai ha−1) were applied posttransplant to nongrafted ‘Amelia' and Amelia scion grafted onto ‘Maxifort' or ‘RST-04-106-T' tomato rootstocks. Although herbicide injury was observed, no differences were observed in grafted and nongrafted tomato response including visible injury assessments, plant height, and fresh weight. Tomato injury at 3 wk after herbicide application increased from 3 to 12, 1 to 87, and 0 to 37% as rate of halosulfuron, metribuzin, and S-metolachlor increased, respectively. In field experiments under plasticulture, herbicides applied pretransplant included fomesafen (280 and 420 g ai ha−1), halosulfuron (39 and 54 g ha−1), metribuzin (280 and 560 g ha−1), napropamide (1,120 and 2,240 g ha−1), S-metolachlor (800 and 1,070 g ha−1), and trifluralin (560 and 840 g ai ha−1). Amelia was used as the scion and the nongrafted control. ‘Anchor-T', ‘Beaufort', or Maxifort tomato were used as rootstocks for grafted plants. Fomesafen, halosulfuron, napropamide, and trifluralin initially caused greater injury to grafted tomato than to nongrafted tomato regardless of rootstock (Anchor-T, Beaufort, or Maxifort). However, by 4 wk after treatment, all grafted and nongrafted plants had recovered from herbicide injury. A transplant type-by-herbicide interaction was not observed for yield, but grafted A-Maxifort tomato produced greater total and marketable yield than nongrafted Amelia tomato. Grafted tomato exhibited similar tolerance as nongrafted tomato for all herbicides applied post- and pretransplant.
Critical Period for Weed Control in Grafted and Nongrafted Fresh Market Tomato
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Samuel J. McGowen, Frank J. Louws
-
- Journal:
- Weed Science / Volume 64 / Issue 3 / September 2016
- Published online by Cambridge University Press:
- 20 January 2017, pp. 523-530
-
- Article
- Export citation
-
Field experiments were conducted to determine the critical period for weed control (CPWC) in nongrafted ‘Amelia’ and Amelia grafted onto ‘Maxifort’ tomato rootstock grown in plasticulture. The establishment treatments (EST) consisted of two seedlings each of common purslane, large crabgrass, and yellow nutsedge transplanted at 1, 2, 3, 4, 5, 6, and 12 wk after tomato transplanting (WAT) and remained until tomato harvest to simulate weeds emerging at different times. The removal treatments (REM) consisted of the same weeds transplanted on the day of tomato transplanting and removed at 2, 3, 4, 5, 6, 8, and 12 WAT to simulate weeds controlled at different times. The beginning and end of the CPWC, based on a 5% yield loss of marketable tomato, was determined by fitting log-logistic and Gompertz models to the relative yield data representing REM and EST, respectively. In both grafted and nongrafted tomato, plant aboveground dry biomass increased as establishment of weeds was delayed and tomato plant biomass decreased when removal of weeds was delayed. For a given time of weed removal and establishment, grafted tomato plants produced higher biomass than nongrafted. The delay in establishment and removal of weeds resulted in weed biomass decrease and increase of the same magnitude, respectively, regardless of transplant type. The predicted CPWC was from 2.2 to 4.5 WAT in grafted tomato and from 3.3 to 5.8 WAT in nongrafted tomato. The length (2.3 or 2.5 wk) of the CPWC in fresh market tomato was not affected by grafting; however, the CPWC management began and ended 1 wk earlier in grafted tomato than in nongrafted tomato.
Twin's Birth-Order Differences in Height and Body Mass Index From Birth to Old Age: A Pooled Study of 26 Twin Cohorts Participating in the CODATwins Project
- Yoshie Yokoyama, Aline Jelenkovic, Reijo Sund, Joohon Sung, John L. Hopper, Syuichi Ooki, Kauko Heikkilä, Sari Aaltonen, Adam D. Tarnoki, David L. Tarnoki, Gonneke Willemsen, Meike Bartels, Toos C. E. M. van Beijsterveldt, Kimberly J. Saudino, Tessa L. Cutler, Tracy L. Nelson, Keith E. Whitfield, Jane Wardle, Clare H. Llewellyn, Abigail Fisher, Mingguang He, Xiaohu Ding, Morten Bjerregaard-Andersen, Henning Beck-Nielsen, Morten Sodemann, Yun-Mi Song, Sarah Yang, Kayoung Lee, Hoe-Uk Jeong, Ariel Knafo-Noam, David Mankuta, Lior Abramson, S. Alexandra Burt, Kelly L. Klump, Juan R. Ordoñana, Juan F. Sánchez-Romera, Lucia Colodro-Conde, Jennifer R. Harris, Ingunn Brandt, Thomas Sevenius Nilsen, Jeffrey M. Craig, Richard Saffery, Fuling Ji, Feng Ning, Zengchang Pang, Lise Dubois, Michel Boivin, Mara Brendgen, Ginette Dionne, Frank Vitaro, Nicholas G. Martin, Sarah E. Medland, Grant W. Montgomery, Patrik K. E. Magnusson, Nancy L. Pedersen, Anna K. Dahl Aslan, Per Tynelius, Claire M. A. Haworth, Robert Plomin, Esther Rebato, Richard J. Rose, Jack H. Goldberg, Finn Rasmussen, Yoon-Mi Hur, Thorkild I. A. Sørensen, Dorret I. Boomsma, Jaakko Kaprio, Karri Silventoinen
-
- Journal:
- Twin Research and Human Genetics / Volume 19 / Issue 2 / April 2016
- Published online by Cambridge University Press:
- 09 March 2016, pp. 112-124
-
- Article
-
- You have access Access
- HTML
- Export citation
-
We analyzed birth order differences in means and variances of height and body mass index (BMI) in monozygotic (MZ) and dizygotic (DZ) twins from infancy to old age. The data were derived from the international CODATwins database. The total number of height and BMI measures from 0.5 to 79.5 years of age was 397,466. As expected, first-born twins had greater birth weight than second-born twins. With respect to height, first-born twins were slightly taller than second-born twins in childhood. After adjusting the results for birth weight, the birth order differences decreased and were no longer statistically significant. First-born twins had greater BMI than the second-born twins over childhood and adolescence. After adjusting the results for birth weight, birth order was still associated with BMI until 12 years of age. No interaction effect between birth order and zygosity was found. Only limited evidence was found that birth order influenced variances of height or BMI. The results were similar among boys and girls and also in MZ and DZ twins. Overall, the differences in height and BMI between first- and second-born twins were modest even in early childhood, while adjustment for birth weight reduced the birth order differences but did not remove them for BMI.
Outbreak of Salmonella Strathcona caused by datterino tomatoes, Denmark, 2011
- L. MÜLLER, C. KJELSØ, C. FRANK, T. JENSEN, M. TORPDAHL, B. SØBORG, F. DORLEANS, W. RABSCH, R. PRAGER, C. M. GOSSNER, S. ETHELBERG
-
- Journal:
- Epidemiology & Infection / Volume 144 / Issue 13 / October 2016
- Published online by Cambridge University Press:
- 05 February 2016, pp. 2802-2811
-
- Article
-
- You have access Access
- HTML
- Export citation
-
In September 2011, a patient cluster with a rare Salmonella serotype – Strathcona – was identified in Denmark. An outbreak investigation was initiated to reveal the source in order to stop the outbreak. In addition to hypothesis-generating interviews, comparable analyses of patients’ household shopping receipts were conducted. A matched case-control study with 25 cases and 56 population register controls was conducted to test the findings of the hypothesis-generating investigation. In total, 43 cases of Salmonella Strathcona were reported in Denmark. Additionally, 28 cases were reported from Germany, Italy, Austria and Belgium. The results of the investigation in Denmark showed that 8/10 cases had bought datterino tomatoes prior to disease onset. Illness was associated with a specific supermarket chain [matched odds ratio (mOR) 16·9, 95% confidence interval (CI) 2·2–130], and having consumed elongated small tomatoes (OR 28·1, 95% CI 2·6–302). Traceback investigation showed that the tomatoes came from an Italian producer. This outbreak, linked to tomatoes, underpins the growing recognition of the broad source range of Salmonella and the ability of fresh produce to cause multi-country outbreaks. It is important to strengthen the international cooperation between public-health and food-safety authorities in the European Union to investigate future multi-country outbreaks in order to prevent illness from ready-to-eat produce.